SCHEMBL30865619

SCHEMBL30865619

CC(C)c1cnc(N(C)C)c2cnc(Cl)cc12

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
LMNA P02545 1/20 0.30
CHEK1 O14757 1/20 0.30
AURKA O14965 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24826757 0.79 LMNA (0.32) LMNA
SCHEMBL30164827 0.79 LMNA (0.32) LMNA
SCHEMBL23578775 0.79 LMNA (0.33) LMNA
SCHEMBL24826762 0.77 LMNA (0.36) LMNA
SCHEMBL24970591 0.72 LMNA (0.35) SMN1; SMN2LMNA
SCHEMBL30865638 0.72
SCHEMBL21872085 0.72 CHEK1 (0.37) SMN1; SMN2LMNACHEK1AURKA
SCHEMBL30865632 0.71 KAT2B (0.36)
SCHEMBL24811604 0.71 KAT2B (0.36)
SCHEMBL30164490 0.71 KDM4E (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117916232-A Heterocyclic EGFR inhibitors for the treatment of cancer 缆图药品公司 2024-04-19 CN disclosed